Emergent BioSolutions | 应收帐款人



金融业
股票价格
USD
资产
USD 1.82B
现金及等价物
USD 111.7M
销售成本
USD 381.2M
流动资产
USD 679.5M
流动负债
USD 651.3M
债务
USD 903.2M
股息收益率
0
EBIT
USD -148.1M
EBITDA
USD -113.5M
员工
1.6K
EPS每股收益
USD -0.77
股本和储备
USD 649.3M
销售毛利
USD 10M
债务利息支出
USD 17.9M
贷款资金
USD 446.5M
市值
USD 120.6M
净收入
USD -261.3M
营业费用
USD 555.9M
营业利润
USD -218M
普通股股本
USD 100K
PE价格收益
14.4
税前利润
USD -130.8M
销售收入
USD 276.6M
销售和管理费用
USD 182.8M
股票
USD 328.9M
贸易债权人
USD 112.2M
应收帐款人
USD 290.1M


应收帐款人 更改 日
Acadia Pharmaceuticals USD 139.44M 19.75M 2025-09
Akebia Therapeutics USD 61.54M 27.17M 2025-03
ALKERMES USD 355.11M 1.22M 2025-09
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amarin USD 127.31M 8.18M 2025-09
ANI Pharmaceuticals USD 252.62M 26.96M 2025-09
BioMarin Pharmaceutical USD 790.27M 65.59M 2025-09
Coherus Biosciences USD 62.44M 59.9M 2025-03
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Exact Sciences USD 306.05M 47.28M 2025-09
Exelixis USD 286.92M 24.38M 2025-12
Glaxosmithkline GBP 11.16B 3.46B 2025-09
Heron Therapeutics USD 67.04M 6.9M 2024-09
Ionis Pharmaceuticals USD 24.61M 27.97M 2025-09
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Lexicon Pharmaceuticals USD 2.62M 1.09M 2024-06
Lonza CHF 1.78B 55M 2025-12
Merck USD 12.12B 596M 2025-09
Moderna USD 184M 862M 2025-12
Myriad Genetics USD 118M 19M 2025-09
Nektar Therapeutics USD 0 2.9M 2024-09
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Pacira USD 115.27M 901K 2025-09
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 203.07M 6.94M 2025-09
Sanofi EUR 397M 100M 2025-12
Sarepta Therapeutics USD 395.74M 213.86M 2025-09
United Therapeutics USD 297.7M 81.6M 2025-09
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Xoma USD 14.78M 4.96M 2024-06


Emergent BioSolutions 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.